Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
July 21, 1984
Neurotoxicity due to the bite of the shield-nose snake (Aspidelaps scutatus). A case report
M Zaltzman, M Rumbak, M Rabie, et al.
Thorax
|
March 1, 1996
Topical treatment of life threatening haemoptysis from aspergillomas
M Rumbak, G Kohler, C Eastrige, et al.
Journal of Child Neurology
|
May 21, 2015
Spinal Fusion for Scoliosis in Rett Syndrome With an Emphasis on Respiratory Failure and Opioid Usage
Dania M Rumbak, Wenzhu Mowrey, Skai W Schwartz, et al.
Critical Care Medicine
|
September 2, 1999
Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group
E Abraham, R Baughman, E Fletcher, et al.
Lancet (London, England)
|
September 12, 1998
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group
E Abraham, A Anzueto, G Gutierrez, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
July 21, 1984
Neurotoxicity due to the bite of the shield-nose snake (Aspidelaps scutatus). A case report
M Zaltzman, M Rumbak, M Rabie, et al.
Thorax
|
March 1, 1996
Topical treatment of life threatening haemoptysis from aspergillomas
M Rumbak, G Kohler, C Eastrige, et al.
Journal of Child Neurology
|
May 21, 2015
Spinal Fusion for Scoliosis in Rett Syndrome With an Emphasis on Respiratory Failure and Opioid Usage
Dania M Rumbak, Wenzhu Mowrey, Skai W Schwartz, et al.
Critical Care Medicine
|
September 2, 1999
Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group
E Abraham, R Baughman, E Fletcher, et al.
Lancet (London, England)
|
September 12, 1998
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group
E Abraham, A Anzueto, G Gutierrez, et al.
Page
of 1